Accessibility Menu
Chemed logo

Chemed(NYSE) CHE

Current Price$504.21
Market Cap$6.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1982)+14,529%
5 Year+8%
1 Year+13%
1 Month+16%
Chemed last closing stock price
MetricPriceDate
Last closeUSD 504.102026-07-21
Chemed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.48%USD 491.892026-07-14
1 month+15.55%USD 436.272026-06-18
3 month+35.28%USD 372.642026-04-22
Year to date+18.13%USD 426.742025-12-31
1 year+12.77%USD 447.012025-07-21
3 year-9.23%USD 555.332023-07-21
5 year+8.09%USD 466.372021-07-22
Since inception+14,528.51%USD 3.451982-06-29

Chemed Financials at a Glance

Market Cap

$6.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.54B

Net Income (TTM)

$259.78M

EPS (TTM)

$18.35

P/E Ratio

27.47

Dividend

$2.40

Beta (Volatility)

0.39 (Low)

Price

$504.21

Volume

2,352.009

Open

$509.94

Previous Close

$504.10

Daily Range

$493.78 - $513.62

52-Week Range

$365.21 - $517.74

Estimated Earnings Date

Jul 28, 2026

CHE: Motley Fool Moneyball Superscore

50

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chemed

Chemed helps families manage end-of-life care for their loved ones. It also fixes home problems like clogged drains and broken pipes. The company serves both homeowners and medical patients across the United States.

What Chemed Does Every Day

  • VITAS: Hospice and palliative care services for terminally ill patients; provides medical, emotional, and spiritual support.
  • Roto-Rooter: Plumbing, drain cleaning, and water restoration for residential and commercial customers.

Growth and Recent Acquisitions

  • Purchased all hospice operations and an assisted living facility from Covenant Health and Community Services in 2024 for $85 million.
  • Acquired three Roto-Rooter franchises in New Jersey, Texas, and Kentucky during 2024 for a combined $12.4 million.
  • Completed the acquisition of a Roto-Rooter franchise in Michigan for $225,000 during 2025.
  • Acquired two Roto-Rooter franchises in South Carolina and Georgia for approximately $4 million in 2023.

Operational Strengths

The company manages its units on a decentralized basis, allowing each brand to focus on its specific market. Roto-Rooter relies on a highly recognized brand name used since 1935, while VITAS operates as one of the largest hospice providers in a fragmented industry.

Financial Performance

  • Revenue reached $639.3 million in Q4 2025, down 0.1% from Q4 2024.
  • Net income was $76.8 million in Q4 2025, down 15% year-over-year.
  • Free cash flow hit $117.2 million in Q4 2025, down 23% from the previous year.
  • Operating income was $100.7 million in Q4 2025, down 11.6% from Q4 2024.

The Bottom Line

Chemed has evolved into a diversified operator focusing on essential healthcare and home services. Its history of strategic acquisitions and decentralized management helps it maintain leadership in two unrelated but stable industries.

AI Generated • Apr 23, 2026

Industry

Healthcare Providers and Services

Employees

15,811

CEO

Kevin J. McNamara

Headquarters

Cincinnati, OH 45202-4726, US

CHE Financials

Key Financial Metrics (TTM)

Gross Margin

30.32%

Operating Margin

12.91%

Net Income Margin

10.23%

Return on Equity

25.33%

Return on Capital

29.82%

Return on Assets

16.91%

Earnings Yield

3.64%

Dividend Yield

0.48%

Payout Ratio

12.53%

Stock Overview

Market Cap

$6.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

13.27M

Volume

2.35K

Avg. Volume

223.17K

Financials (TTM)

Gross Profit

$770.25M

Operating Income

$328.07M

EBITDA

$418.12M

Operating Cash Flow

$443.75M

Capital Expenditure

-$66.63M

Free Cash Flow

$377.12M

Cash & ST Invst.

$16.86M

Total Debt

$236.93M

Chemed Performance Analysis

Chemed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,134,963,000-0.2%
20232023-12-31USD 2,264,417,0006.1%
20242024-12-31USD 2,431,287,0007.4%
20252025-12-31USD 2,529,978,0004.1%
Chemed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-4.4%
Q32025-09-301.0%
Q42025-12-312.3%
Q12026-03-312.8%
Chemed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 16.53-1.9%
20232023-12-31USD 17.938.4%
20242024-12-31USD 19.8910.9%
20252025-12-31USD 18.34-7.8%
Chemed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-26.5%
Q32025-09-3024.9%
Q42025-12-3122.9%
Q12026-03-31-11.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$657.51M

+1.6%

Gross Profit

$198.89M

-8.1%

Gross Margin

30.25%

N/A

Market Cap

$6.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$423.22K

N/A

Employees

15,811

N/A

Net Income

$66.30M

-7.6%

EBITDA

$106.23M

-5.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$16.86M

-90.3%

Total Debt

$236.93M

+63.3%

Accounts Receivable

$215.48M

-24.6%

Inventory

$7.21M

-7.5%

Long Term Debt

$195.65M

+91.7%

Short Term Debt

$41.29M

-3.9%

Return on Assets

16.91%

N/A

Return on Invested Capital

27.01%

N/A

Free Cash Flow

$71.10M

+265.3%

Operating Cash Flow

$88.22M

+169.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TFXTeleflex Incorporated
$135.01+0.73%
MTSRMetsera, Inc.
$70.50-0.35%
STVNStevanato Group S.p.A.
$19.10-0.26%
ATRAptarGroup, Inc.
$128.91-0.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$35.14+0.24%
TAT&T
$22.26+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.31-0.06%
NOKNokia
$10.63+0.05%

Questions About CHE

What is the current price of Chemed?

Chemed is trading at $504.10 per share.

What is the 52-week range for Chemed?

Over the past 52 weeks, Chemed has traded between $365.21 and $517.74.

How much debt does Chemed have?

As of the most recent reporting period, Chemed reported total debt of $247.43M.

How much cash does Chemed have on hand?

Chemed reported $16.86M in cash and cash equivalents in its most recent financial results.

What is Chemed’s dividend yield?

Chemed currently has a dividend yield of 0.48%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.